European Safety Reporting Requirements during Clinical Investigations
European Safety Reporting Requirements during Clinical Investigations
This course provides a review of the overall regulatory requirements for adverse event reporting during clinical investigations in Europe including an outline of the applicable documents and what the different reporting requirements are for both competent authorities and ethics committees. The course takes into account the requirements of EU-MDR and related MDCG 2020-10.
ID: 82
25 minutes
2 modules
Learning Objectives
Upon successfully completing this course, learners will be able to:
-
Comply with the EU regulations on Serious Adverse Event reporting during clinical investigations
-
Implement the EU requirements into a company’s quality system procedures for safety reporting during clinical investigations
- Set clear timelines for all parties involved especially the clinical investigators to record, report and review serious adverse event reporting
Who Should Enroll
Clinical research associates (monitors), senior clinical research associates, clinical project and compliance managers, clinical quality associates and managers, clinical affairs directors, clinical safety managers, and clinical and regulatory professionals from the pharmaceutical industry wanting to understand the regulatory differences in safety reporting during clinical investigations with medical devices are all encouraged to enroll in this course.
Prerequisite Knowledge
The following courses are required:
- Ethics Committee (EC)/Institutional Review Board Requirements (ID 46)
- Adverse Event Processes (ID 59)
General Requirements for WMDO Courses
-
Course Access Duration: Each course is available for 60 days from the date of assignment.
-
Quiz Completion: Users are allowed 2 attempts to complete each quiz, with a minimum passing score of 75%.